GO:0098633 collagen fibril binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098633 (collagen fibril binding) is a molecular function defined as binding to a collagen fibril.
• Collagen fibrils are supramolecular assemblies of triple-helical collagen molecules; their surface presents both constitutive and cryptic binding sites for receptors and matrix proteins.
• Key collagen fibril-binding proteins include integrins, DDR1/DDR2, fibronectin, and proteoglycans, which interact with specific sequence motifs in the fibril.
• Cryptic binding sites within the fibril can become exposed through mechanical or structural remodeling, regulating cell-matrix communication.
• Mutations in type I collagen that alter fibril-binding interfaces cause osteogenesis imperfecta and related connective tissue disorders.
• CRISPR knockout, point-mutation, and knock-in models are essential to dissect the causal roles of collagen fibril-binding proteins in development and disease.
Description
Collagen fibril binding (GO:0098633) is a molecular function that describes the selective interaction of a protein or other molecule with a collagen fibril. Collagen fibrils are the principal tensile elements of the extracellular matrix in connective tissues such as tendon, bone, skin, and cornea. These fibrils are not inert scaffolds; their surfaces display specific binding sites that mediate cell adhesion, matrix assembly, and signaling. Understanding collagen fibril binding is therefore central to matrix biology, tissue engineering, and the pathophysiology of connective tissue diseases. The function is mediated by a diverse set of proteins, including integrins, discoidin domain receptors (DDRs), fibronectin, and proteoglycans, which recognize distinct structural features of the fibril. Recent work has revealed that some binding sites are cryptic in the native fibril and become accessible only after structural remodeling, adding a layer of dynamic regulation to this function. This article synthesizes authoritative GO annotation and published literature to provide a research-grade overview of collagen fibril binding, its molecular mechanisms, associated genes, disease relevance, and experimental strategies for investigation.
collagen fibril binding At A Glance
| GO ID | GO:0098633 |
|---|---|
| GO term | collagen fibril binding |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binding to a collagen fibril. |
| Major function | Mediates adhesion, signaling, and assembly of extracellular matrix components to collagen fibrils. |
| Representative binders | Integrins, DDR1, DDR2, fibronectin, proteoglycans, collagen telopeptide-binding proteins. |
| Structural basis | Recognition of specific sequences or cryptic epitopes on the fibril surface. |
| Disease relevance | Osteogenesis imperfecta, fibrosis, cancer, and connective tissue disorders. |
What Is GO:0098633?
According to the Gene Ontology, GO:0098633 collagen fibril binding is the molecular function of binding to a collagen fibril. A collagen fibril is a supramolecular assembly of collagen molecules, typically formed by staggered triple-helical monomers that are covalently cross-linked. This binding function is distinct from binding to individual collagen molecules or to other collagenous structures; it specifically requires the fibrillar architecture. The interaction can involve direct recognition of amino acid sequences on the fibril surface, or it can be mediated by conformational epitopes that arise from fibril assembly.
Why Is collagen fibril binding Important in Cell Biology?
Collagen fibril binding is fundamental to how cells sense and remodel their mechanical environment. It governs cell adhesion, migration, proliferation, and differentiation through receptors such as integrins and DDRs. It also controls the assembly of other matrix components, as exemplified by fibronectin fibrillogenesis directed by a specific binding site in type I collagen. Dysregulation of these interactions contributes to a wide range of pathologies, including osteogenesis imperfecta, fibrosis, and cancer progression. Moreover, the exposure of cryptic binding sites within collagen fibrils provides a mechanism for mechanotransduction and tissue remodeling. Thus, studying collagen fibril binding is essential for understanding development, tissue homeostasis, and disease, and for designing biomaterials that mimic or target collagen matrices.
• Collagen fibril binding mediates cell-matrix adhesion through integrins and DDR receptors.
• It regulates collagen fibrillogenesis and matrix assembly, including fibronectin fibril formation.
• Cryptic binding sites in collagen fibrils enable mechanosensitive signaling and tissue remodeling.
• Mutations in collagen that alter fibril-binding interfaces cause osteogenesis imperfecta and related disorders.
• Collagen fibril binding is implicated in cancer progression, where altered matrix interactions promote invasion.
• It is critical for tendon and bone biomechanics, as fibril-binding proteins influence fibril orientation and cross-linking.
• Targeting collagen fibril-binding interactions is a strategy for antifibrotic and anticancer therapies.
• Collagen telopeptide-binding peptides can aid collagen bundle formation and fibril orientation, with applications in tissue engineering.
• Understanding collagen fibril binding informs the design of biomaterials with controlled cell-adhesive properties.
• GO:0098633 provides a standardized annotation for functional genomics and proteomics studies of matrix interactions.
What Happens During collagen fibril binding?
Recognition of the collagen fibril surface
In simple terms: Proteins find and stick to specific spots on the surface of collagen fibrils.
The first step in collagen fibril binding is the recognition of binding sites on the fibril surface. Collagen fibrils are composed of triple-helical molecules arranged in a staggered pattern, creating a periodic surface with distinct chemical and structural features. Some binding sites are constitutively exposed, such as the integrin-binding GFOGER motif in type I collagen, while others are cryptic and become available only after structural remodeling. For example, the DDR receptors recognize specific sequence motifs in the collagen triple helix, and their binding is influenced by the fibrillar context. Fibronectin binds to a site in type I collagen that regulates fibronectin fibril formation, illustrating the specificity of these interactions.
Conformational changes and receptor activation
In simple terms: When a receptor binds to collagen, it changes shape and sends signals into the cell.
Binding to collagen fibrils often induces conformational changes in the interacting protein, leading to receptor activation or structural reorganization. DDR1 and DDR2 are receptor tyrosine kinases that undergo dimerization and autophosphorylation upon collagen binding, initiating downstream signaling. Integrins cluster upon ligand binding, forming focal adhesions that link the extracellular matrix to the cytoskeleton. These conformational changes are essential for translating the mechanical and biochemical properties of the fibril into cellular responses.
Matrix assembly and fibril organization
In simple terms: Binding proteins help organize collagen fibrils and other matrix components into ordered structures.
Collagen fibril binding is not only a recognition event but also a driver of matrix assembly. Fibronectin binding to type I collagen regulates the formation of fibronectin fibrils, which in turn influence collagen fibril organization. Collagen telopeptide-binding peptides can promote collagen bundle formation and fibril orientation, suggesting that specific binders can modulate the supramolecular architecture of collagen. Proteoglycans and other matrix proteins also bind to collagen fibrils and contribute to tissue-specific fibril organization and mechanical properties.
Dynamic regulation by cryptic site exposure
In simple terms: Some binding sites are hidden until the fibril is stretched or remodeled, allowing dynamic control of interactions.
A key feature of collagen fibril binding is the existence of cryptic binding sites that are buried in the native fibril and become exposed upon mechanical loading or proteolytic remodeling. Hoop et al. demonstrated that cryptic protein binding sites within the functional collagen fibril can be revealed by changes in hydration or mechanical strain. Zhu et al. showed that surface reconstruction of the type I collagen fibril exposes cryptic binding sites, which may facilitate cell-matrix interactions during tissue repair. This dynamic exposure provides a mechanism for mechanotransduction and for spatiotemporal regulation of matrix assembly and cell signaling.
Key Genes Involved in GO:0098633 collagen fibril binding
The following genes encode proteins that directly or indirectly mediate collagen fibril binding, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| COL1A1 | Encodes the alpha-1 chain of type I collagen, the major component of collagen fibrils | Mutations cause osteogenesis imperfecta; binding sites for integrins and proteoglycans are located in the helical domain |
| COL1A2 | Encodes the alpha-2 chain of type I collagen | Mutations cause osteogenesis imperfecta; involved in fibril assembly and receptor binding |
| ITGB1 | Integrin beta-1 subunit, forms heterodimers that bind collagen fibrils | Mediates cell adhesion to collagen; key for mechanotransduction |
| ITGA1 | Integrin alpha-1 subunit, pairs with beta-1 to bind collagen | Recognizes GFOGER motif in type I collagen; involved in matrix remodeling |
| ITGA2 | Integrin alpha-2 subunit, collagen receptor | Binds collagen fibrils and regulates cell migration and differentiation |
| DDR1 | Discoidin domain receptor 1, collagen-activated tyrosine kinase | Binds collagen fibrils and regulates cell proliferation, adhesion, and matrix remodeling |
| DDR2 | Discoidin domain receptor 2, collagen-activated tyrosine kinase | Binds collagen fibrils; mutations cause skeletal disorders |
| FN1 | Fibronectin, binds to type I collagen and regulates fibril formation | Its binding site in collagen regulates fibronectin fibril formation |
| SPARC | Secreted protein acidic and rich in cysteine, binds collagen fibrils | Modulates collagen fibril assembly and cell-matrix interactions |
| LUM | Lumican, a small leucine-rich proteoglycan that binds collagen fibrils | Regulates collagen fibril diameter and organization in connective tissues |
| DCN | Decorin, a small leucine-rich proteoglycan that binds collagen fibrils | Influences collagen fibrillogenesis and tissue mechanics |
| FMOD | Fibromodulin, binds collagen fibrils | Regulates collagen fibril assembly in tendon and cartilage |
| COMP | Cartilage oligomeric matrix protein, binds collagen fibrils | Mutations cause skeletal dysplasias; involved in fibril organization |
| THBS1 | Thrombospondin-1, binds collagen fibrils | Modulates cell adhesion and matrix remodeling |
| VWF | von Willebrand factor, binds collagen fibrils | Mediates platelet adhesion to collagen in hemostasis |
| GP6 | Glycoprotein VI, platelet collagen receptor | Binds collagen fibrils to trigger platelet activation |
| COL3A1 | Type III collagen, forms fibrils and binds integrins | Mutations cause vascular Ehlers-Danlos syndrome; involved in fibril assembly |
How Is collagen fibril binding Regulated?
Collagen fibril binding is regulated at multiple levels. The availability of binding sites on the fibril surface is controlled by the assembly state of collagen, as cryptic sites become exposed upon mechanical strain or proteolytic remodeling. Post-translational modifications of collagen, such as lysine hydroxylation and glycosylation, can influence receptor recognition. The expression levels of receptors such as integrins and DDRs are regulated by growth factors and cytokines, thereby modulating cellular capacity to bind collagen fibrils. Additionally, extracellular matrix proteins like fibronectin can compete or cooperate with other binders, affecting the overall interaction network. Mechanical forces also play a role by altering fibril conformation and exposing cryptic epitopes.
collagen fibril binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| COL1A1 | Osteogenesis imperfecta; bone fragility | Knock-in mouse carrying Gly->Cys mutation; patient-derived iPSCs |
| COL1A2 | Osteogenesis imperfecta; connective tissue weakness | CRISPR point-mutation in COL1A2 helical domain; osteoblast differentiation assays |
| DDR1 | Cancer progression; fibrosis | Knockout mice; organoid models with DDR1 deletion |
| DDR2 | Skeletal dysplasia; osteoarthritis | Knock-in mice with DDR2 mutations; chondrocyte cultures |
| FN1 | Fibronectin fibrillogenesis; matrix assembly | Knockout fibronectin; collagen-binding domain deletion mutants |
Osteogenesis imperfecta and collagen mutations
Osteogenesis imperfecta (OI) is a genetic disorder characterized by bone fragility, caused predominantly by mutations in COL1A1 and COL1A2. Many of these mutations affect the helical domain of type I collagen, which contains binding sites for integrins and proteoglycans. Disruption of these binding interfaces impairs cell-matrix interactions and bone quality, highlighting the importance of collagen fibril binding in skeletal health.
Fibrosis and aberrant matrix remodeling
Fibrotic diseases are characterized by excessive deposition and remodeling of collagen fibrils. Altered collagen fibril binding by integrins and DDRs contributes to fibroblast activation and matrix stiffening. Cryptic binding sites exposed during fibrosis may further amplify pro-fibrotic signaling, making these interactions attractive therapeutic targets.
Cancer progression and metastasis
In cancer, increased collagen deposition and cross-linking remodel the tumor microenvironment. Collagen fibril binding by integrins and DDRs promotes cancer cell proliferation, invasion, and metastasis. Targeting these interactions, for example with DDR inhibitors, is an active area of anticancer research.
Connective tissue disorders and tendon pathology
Mutations in collagen genes or in genes encoding collagen-binding proteoglycans cause connective tissue disorders such as Ehlers-Danlos syndrome and tendon dysfunction. Collagen fibril binding by proteoglycans like decorin and lumican regulates fibril diameter and mechanical properties, and its disruption leads to tissue fragility.
From collagen fibril binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate collagen-binding protein affect fibril organization? | CRISPR knockout in fibroblasts or osteoblasts; imaging of collagen fibrils |
| Does a specific point mutation in the collagen-binding domain alter receptor interaction? | CRISPR point mutation knock-in in COL1A1 or COL1A2; binding assays |
| Can a tagged version of a collagen-binding protein be used to track its localization? | Knock-in of fluorescent tag (e.g., GFP) at the endogenous locus; live-cell imaging |
| Does overexpression of a collagen-binding protein alter matrix assembly? | Overexpression via lentiviral transduction; collagen gel contraction assays |
| Which genes regulate collagen fibril binding in a genome-wide manner? | CRISPR library screening with a collagen-binding readout; bioinformatics analysis |
| Does a disease-associated mutation affect collagen fibril binding affinity? | Point-mutation knock-in in cell lines; surface plasmon resonance or ELISA-based binding assays |
How to Study the collagen fibril binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance (SPR) | Binding affinity and kinetics | Quantify interactions between collagen fibrils and recombinant proteins |
| Solid-phase binding assay | Specific binding of proteins to immobilized collagen | Screen for binding specificity and competition |
| Second harmonic generation microscopy | Collagen fibril orientation and density | Assess fibril organization in tissues and engineered matrices |
| Atomic force microscopy | Fibril surface topography and mechanical properties | Study cryptic site exposure and fibril deformation |
| CRISPR knockout screening | Genes required for collagen fibril binding | Identify novel regulators in a genome-wide manner |
| Affinity proteomics | Protein composition of collagen-binding complexes | Discover new collagen fibril-binding proteins |
| Tensile testing | Mechanical properties of collagen-rich tissues | Correlate molecular interactions with tissue strength |
Binding assays for collagen fibril interactions
Direct binding of proteins to collagen fibrils can be measured using solid-phase binding assays, surface plasmon resonance (SPR), or enzyme-linked immunosorbent assays (ELISA) with purified collagen fibrils. These methods allow determination of affinity, specificity, and the effects of mutations in either the collagen or the binding protein. For cryptic sites, pre-treatment of fibrils with mechanical strain or proteases may be necessary to expose the epitope.
Imaging collagen fibril organization and binding
Electron microscopy, atomic force microscopy, and second harmonic generation microscopy can visualize collagen fibril structure and organization. Fluorescently tagged binding proteins or antibodies can be used to localize binding sites on fibrils in tissues or in vitro. Live-cell imaging of tagged receptors (e.g., DDR1-GFP) enables real-time monitoring of binding dynamics.
Genetic and proteomic screens
CRISPR knockout or activation screens coupled with a collagen-binding readout can identify genes that regulate this function. Proteomic approaches such as affinity purification with collagen fibrils followed by mass spectrometry can uncover novel binders. Bioinformatics analysis of transcriptomic and proteomic data can reveal pathways and networks associated with collagen fibril binding.
Biomechanical testing
Tensile testing of tendons, ligaments, or engineered tissues provides functional readouts of collagen fibril organization and cross-linking. These measurements can be correlated with binding protein expression or mutations to understand how molecular interactions translate into tissue mechanics.
How CRISPR Can Be Used to Study GO:0098633 collagen fibril binding
Knockout
CRISPR knockout of genes encoding candidate collagen fibril-binding proteins (e.g., DDR1, ITGB1) allows assessment of their necessity for cell adhesion, matrix assembly, and signaling. Knockout cell lines can be used in binding assays and imaging to determine loss-of-function phenotypes.
Point Mutation
Introducing precise point mutations in collagen genes (e.g., COL1A1) that alter binding motifs (such as the GFOGER sequence) enables dissection of specific interaction interfaces. Point-mutation knock-in models can mimic human disease mutations and reveal their impact on collagen fibril binding.
Knock-in
Knock-in of tags (e.g., GFP, HA) at endogenous loci of collagen-binding proteins facilitates tracking of their localization and dynamics in live cells. Knock-in of disease-associated mutations in collagen or receptor genes provides physiologically relevant models.
Overexpression
Overexpression of collagen fibril-binding proteins or their mutant variants can be achieved via lentiviral transduction or CRISPR activation. This approach helps determine sufficiency and dominant-negative effects on matrix assembly and cell behavior.
How EDITGENE Supports collagen fibril binding Research
Researchers studying collagen fibril binding-related genes often need to determine whether a candidate gene is causally involved in matrix assembly, cell adhesion, or disease pathogenesis. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of collagen fibril-binding proteins and their interactions.
Contact EDITGENE today to design your custom CRISPR model for collagen fibril binding research.
Frequently Asked Questions About collagen fibril binding
What is GO:0098633 collagen fibril binding?
GO:0098633 is a Gene Ontology molecular function term defined as binding to a collagen fibril. It describes the selective interaction of proteins with the supramolecular assembly of collagen molecules.
What genes are involved in collagen fibril binding?
Key genes include COL1A1, COL1A2, ITGB1, ITGA1, ITGA2, DDR1, DDR2, FN1, and proteoglycans such as LUM and DCN.
How does collagen fibril binding regulate cell signaling?
Binding to collagen fibrils activates receptors like integrins and DDRs, triggering downstream signaling that controls cell adhesion, proliferation, and matrix remodeling.
What are cryptic binding sites in collagen fibrils?
Cryptic binding sites are regions on the collagen fibril that are buried in the native structure and become exposed upon mechanical strain or remodeling, allowing dynamic protein interactions.
Which diseases are associated with defective collagen fibril binding?
Osteogenesis imperfecta, Ehlers-Danlos syndrome, fibrosis, and cancer are associated with altered collagen fibril binding.
How can I study collagen fibril binding in the lab?
Common methods include surface plasmon resonance, solid-phase binding assays, second harmonic generation imaging, and CRISPR screens.
What is the role of fibronectin in collagen fibril binding?
Fibronectin binds to a specific site in type I collagen, and this interaction regulates fibronectin fibril formation and matrix assembly.
Can CRISPR be used to model collagen fibril binding diseases?
Yes, CRISPR knockout, point mutation, and knock-in models can replicate disease-associated mutations and dissect their effects on collagen fibril binding.
What experimental models are suitable for studying collagen fibril binding?
Knockout mice, patient-derived iPSCs, and engineered cell lines with tagged or mutant collagen-binding proteins are commonly used.
How does collagen fibril binding affect tissue mechanics?
Collagen fibril binding by proteoglycans and other matrix proteins influences fibril diameter, orientation, and cross-linking, which determine tissue tensile strength.
Conclusion
Collagen fibril binding (GO:0098633) is a fundamental molecular function that governs cell-matrix interactions, matrix assembly, and tissue mechanics. Its dysregulation underlies a spectrum of diseases, from osteogenesis imperfecta to fibrosis and cancer. Advances in CRISPR-based models and imaging technologies continue to unravel the dynamic nature of collagen fibril binding, including the exposure of cryptic sites. EDITGENE's services empower researchers to create precise genetic models for functional studies of collagen fibril-binding proteins, accelerating discoveries in matrix biology and therapeutic development.
References
- 1. Marini JC et al.. 2007. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.. Hum Mutat 28(3):209-21 PMID: 17078022
- 2. Orgel JPRO et al.. 2019. A structural prospective for collagen receptors such as DDR and their binding of the collagen fibril.. Biochim Biophys Acta Mol Cell Res 1866(11):118478 PMID: 31004686
- 3. Hoop CL et al.. 2017. Revealing Accessibility of Cryptic Protein Binding Sites within the Functional Collagen Fibril.. Biomolecules 7(4) PMID: 29104255
- 4. Kannus P. 2000. Structure of the tendon connective tissue.. Scand J Med Sci Sports 10(6):312-20 PMID: 11085557
- 5. Bella J et al.. 2017. Fibrillar Collagens.. Subcell Biochem 82:457-490 PMID: 28101870
- 6. Zhu J et al.. 2018. Cryptic binding sites become accessible through surface reconstruction of the type I collagen fibril.. Sci Rep 8(1):16646 PMID: 30413772
- 7. Yang W et al.. 2017. A collagen telopeptide binding peptide shows potential in aiding collagen bundle formation and fibril orientation.. Biomater Sci 5(9):1766-1776 PMID: 28650004
- 8. Dzamba BJ et al.. 1993. Fibronectin binding site in type I collagen regulates fibronectin fibril formation.. J Cell Biol 121(5):1165-72 PMID: 8501121
